Location: Home
  • search
  • go
  • Relate News
  • 8/3/2021WuXi STA Completes Acquisition of BMS Manufacturing Facility in Couvet...
  • 8/3/2021India Initiates Anti-dumping Probe against Chemical from China for Ato...
  • 8/3/2021BeiGene Announces Plans to Build New Manufacturing and Clinical R&D Ce...
  • 8/3/2021111, Inc. Enters into Strategic Deal with Zelgen for a New iver Cancer...
  • 8/3/2021"Unofficial" Chinese Orange Book User Guide For Pharmaceutical Patents
  • 8/3/2021Bribery in China: Hospital Purchases Pose A FCPA Concern for Healthcar...
  • 8/3/2021PharmaDJ: June Numbers Spike with a Big In-Licensing Deal
  • 8/2/2021The Exponential Growth Potential of Asia's Pharmaceutical Markets
  • 8/2/2021Chinese Biosimilars Surge between 2018 and 2020 Due to New NMPA Regula...
  • 8/2/2021Biopharma Companies Still Waiting for Clarity on China's New Patent Te...
  • 8/2/2021China Snapping Up Drug Rights in Taiwan
  • 8/2/2021Review of China Healthcare Financing 2014-2021
  • 8/2/2021SMEI: Chinese Retail Pharmacy Market (Offline and Online) Rose 12.5% i...
  • 8/2/2021SMEI Predicts Restructure of Chinese Drug Retail Market and Further Bo...
  • 8/2/2021Eisai's Anti-Epileptic Fycompa Approved in China as Monotherapy for Pa...
  • 8/2/2021WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Cert...
  • 8/2/2021CANbridge CAN103 Investigational NDA Accepted by NMPA
  • 8/2/2021Zentera Secures $75M Series B Financing as It Eyes HK IPO
  • 8/1/2021NHSA Publicizes the List of Drugs Passing Form Evaluation for Inclusio...
  • 8/1/2021Can AstraZeneca Sustain Rapid Growth in China amid Price-Cutting Schem...
  • 7/30/2021China Begins to Deploy Patent Linkage as NMPA Tempted to Set Higher Ba...
  • 7/30/2021Financial-related Company News in Brief (July 2021)
  • 7/30/2021Review of Chinese Drug Registration Application and Evaluation in H1/2...
  • 7/30/2021Recent Executive Moves
  • 7/29/2021SMEI: Chinese Drug Market under Transformation with Growing ex-Hospita...
  • 7/29/2021Junshi's Chinese sNDA for Toripalimab Plus Chemotherapy as First-Lin...
  • 7/29/2021Guobang Pharma's IPO to Debut on Shanghai Stock Exchange
  • 7/29/2021AstraZeneca's China Business Growth Slows in Q2/2021 amid VBP Uncertai...
  • 7/29/2021Ping An-Shionogi Joint Venture Launched in Shanghai
  • 7/29/2021Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D a...
  • Page:191/789 Total number of articles:23668: [First][<<] [189] [190] [191] [192] [193] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group